WCN26-1850 CLINICAL UTILITY OF WHOLE-GENOME SEQUENCING IN ALPORT SYNDROME: A CASE SERIES OF DEEP INTRONIC AND COPY NUMBER VARIANTS

Read full text Summarise with VIRAT
Authors: Asahi Yamamoto, China Nagano, Shuhei Aoyama, Yuka Kimura, Yuta Inoki, Nana Sakakibara, Tomoko Horinouchi, Tomohiko Yamamura, Shingo Ishimori, Anna Kobayashi, Takayuki Okamoto, Kandai Nozu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Alport syndrome is a hereditary glomerular disorder caused by pathogenic variants in COL4A3, COL4A4, or COL4A5, encoding type IV collagen α-chains. It is characterized by hematuria, progressive renal dysfunction, sensorineural hearing loss, and ocular abnormalities. Genetic testing is essential for confirming the diagnosis, progression, and donor selection. However, targeted exome sequencing often fails to detect certain variant types, especially deep intronic variants and large deletions. We evaluated the clinical utility of whole-genome sequencing (WGS) in three pediatric patients with clinically suspected Alport syndrome who remained genetically undiagnosed after targeted exome sequencing.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Genomics and Rare Diseases Genetic and Kidney Cyst Diseases

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105085–105085
Publication date
25 March 2026
Language
EN